153 related articles for article (PubMed ID: 27974690)
41. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.
Jimenez RE; Folpe AL; Lapham RL; Ro JY; O'Shea PA; Weiss SW; Amin MB
Am J Surg Pathol; 2002 Mar; 26(3):320-7. PubMed ID: 11859203
[TBL] [Abstract][Full Text] [Related]
42. Sarcomatoid non-small cell lung cancer responding to sunitinib.
Schultheis B; Kummer G; Strumberg D
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):87-8. PubMed ID: 23260010
[No Abstract] [Full Text] [Related]
43. [PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].
Namura K; Otake S; Sawada T; Fujikawa A; Ota J; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):30-4. PubMed ID: 26399128
[TBL] [Abstract][Full Text] [Related]
44. Multifocal microcysts and papillary cystadenoma of the lung in von Hippel-Lindau disease.
Klein J; Zhuang Z; Lubensky I; Colby TV; Martinez F; Leslie KO
Am J Surg Pathol; 2007 Aug; 31(8):1292-6. PubMed ID: 17667557
[TBL] [Abstract][Full Text] [Related]
45. Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.
Basille D; Andrejak M; Bentayeb H; Kanaan M; Fournier C; Lecuyer E; Boutemy M; Garidi R; Douadi Y; Dayen C
Ann Pharmacother; 2010 Feb; 44(2):383-6. PubMed ID: 20118139
[TBL] [Abstract][Full Text] [Related]
46. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review.
Rao Q; Zhou J; Wang JD; Jin XZ; Ma HH; Lu ZF; Zhou XJ
Ann Diagn Pathol; 2010 Oct; 14(5):361-4. PubMed ID: 20850701
[TBL] [Abstract][Full Text] [Related]
47. Lung Aspergillosis in renal cell carcinoma patient treated with sunitinib.
Visvardis EE; Gao F; Paes MN; Duprez O; Waxman J
QJM; 2012 Jul; 105(7):689-92. PubMed ID: 21693543
[No Abstract] [Full Text] [Related]
48. Advances in personalized therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivity.
Swanton C; Burrell RA
Cancer Biol Ther; 2009 Nov; 8(21):2051-3. PubMed ID: 19816149
[No Abstract] [Full Text] [Related]
49. Early dural metastasis from a case of glioblastoma with primitive neuroectodermal differentiation: A case report and literature review.
Konar SK; Bir SC; Maiti TK; Patra DP; DiPoto Brahmbhatt AC; Jacobsohn JA; Nanda A
J Clin Neurosci; 2017 Jan; 35():78-81. PubMed ID: 28029420
[TBL] [Abstract][Full Text] [Related]
50. Sunitinib for treatment of advanced renal cell cancer: primary tumor response.
van der Veldt AA; Meijerink MR; van den Eertwegh AJ; Bex A; de Gast G; Haanen JB; Boven E
Clin Cancer Res; 2008 Apr; 14(8):2431-6. PubMed ID: 18413834
[TBL] [Abstract][Full Text] [Related]
51. Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.
Zimmermann K; Schmittel A; Steiner U; Asemissen AM; Knoedler M; Thiel E; Miller K; Keilholz U
Oncology; 2009; 76(5):350-4. PubMed ID: 19321976
[TBL] [Abstract][Full Text] [Related]
52. Efficiency of Sunitinib in Chinese Patients with Advanced Progressive Pancreatic Neuroendocrine Tumor.
Gao HL; Ying HY; Cheng YJ; Meng CT; Bai CM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):300-4. PubMed ID: 27469915
[TBL] [Abstract][Full Text] [Related]
53. Adrenal adenoma in von Hippel-Lindau syndrome: A case report with review of literature.
Palui R; Kamalanathan S; Sahoo J; Dorairajan LN; Badhe B; Gochhait D
J Cancer Res Ther; 2019 Mar; 15(Supplement):S163-S166. PubMed ID: 30900640
[TBL] [Abstract][Full Text] [Related]
54. Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease.
Kobayashi A; Takahashi M; Imai H; Akiyama S; Sugiyama S; Komine K; Saijo K; Takahashi M; Takahashi S; Shirota H; Sato N; Fujishima F; Shuin T; Shimodaira H; Ishioka C
Intern Med; 2016; 55(6):629-34. PubMed ID: 26984080
[TBL] [Abstract][Full Text] [Related]
55. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
[TBL] [Abstract][Full Text] [Related]
56. Metastatic adrenocortical carcinoma treated with sunitinib: a case report.
Lee JO; Lee KW; Kim CJ; Kim YJ; Lee HE; Kim H; Kim JH; Bang SM; Kim JS; Lee JS
Jpn J Clin Oncol; 2009 Mar; 39(3):183-5. PubMed ID: 19168875
[TBL] [Abstract][Full Text] [Related]
57. von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
Choueiri TK; Vaziri SA; Jaeger E; Elson P; Wood L; Bhalla IP; Small EJ; Weinberg V; Sein N; Simko J; Golshayan AR; Sercia L; Zhou M; Waldman FM; Rini BI; Bukowski RM; Ganapathi R
J Urol; 2008 Sep; 180(3):860-5; discussion 865-6. PubMed ID: 18635227
[TBL] [Abstract][Full Text] [Related]
58. A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib.
Li T; Wang L; Wang H; Zhang S; Atikan Kawuli ; Zhang X; Luo Z; Wang C
Invest New Drugs; 2016 Dec; 34(6):701-706. PubMed ID: 27604635
[TBL] [Abstract][Full Text] [Related]
59. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors.
Bisht S; Feldmann G; Brossart P
Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):777-88. PubMed ID: 23590356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
